StockWatch
·
Pharmaceuticals
AGM/EGM4 Sept 2026, 08:50 pm

Jenburkt Pharmaceuticals Holds 41st AGM via Video Conference

AI Summary

Jenburkt Pharmaceuticals Limited conducted its 41st Annual General Meeting (AGM) on September 4, 2026, entirely through Video Conference/Other Audio-Visual Means (VC/OAVM). The meeting commenced at 3:30 PM IST and concluded at 4:50 PM IST. The company facilitated remote e-voting for shareholders from September 1st to September 3rd, 2026, with an option for in-meeting voting. The proceedings included introductions from the board and auditors, and the Chairman highlighted the company's 41-year journey themed "Ripples of Change," emphasizing consistent decisions rooted in integrity and purpose. Statutory and secretarial auditors' reports were presented without adverse qualifications.

Key Highlights

  • 41st Annual General Meeting held via Video Conference on September 4, 2026.
  • Remote e-voting facility provided to shareholders prior to the AGM.
  • Chairman highlighted company's 41-year journey and core values.
  • Statutory and secretarial auditors' reports confirmed no adverse qualifications.